| http://www.w3.org/ns/prov#value | - In brief, the F.I.R.E. trial was a double-blind, randomized, placebo-controlled multicentre-trial performed in 2006???2008, including 234 patients, to study the effects of FX06 on reperfusion damage in patients undergoing primary PCI for STEMI presenting within 6 hours from onset of symptoms.
|
